5 Best Multibagger Penny Stocks To Buy

4. InflaRx N.V. (NASDAQ:IFRX)

Stock Gains Over the Past One Year: 221%

Germany-based InflaRx N.V. (NASDAQ:IFRX) makes inhibitors using C5a technology for a variety of autoimmune and other inflammatory diseases. InflaRx N.V. (NASDAQ:IFRX) is up about 221% over the past one year. InflaRx N.V. (NASDAQ:IFRX) recently appointed Dr. Camilla Chong as Chief Medical Officer (CMO) of InflaRx, effective July 1, 2023.

InflaRx N.V. (NASDAQ:IFRX) recently launched a treatment for critically ill COVID-19 hospitalized patients.

As of the end of the first quarter of 2023, 3 hedge funds tracked by Insider Monkey had stakes in this multibagger penny stock. The biggest stakeholder of InflaRx N.V. (NASDAQ:IFRX) was Aaron Cowen’s Suvretta Capital Management which owns a $4.2 million stake in the company.